InsiderTrades

Form 4 for ELV Elevance Health

Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001156039-24-000033 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-03-05 2024-03-01 ELV Todt Blair Williams EVP, CLO, CAO A - Grant $0.00 +8,691 10.6K +451% $0
D 2024-03-05 2024-03-01 ELV Todt Blair Williams EVP, CLO, CAO F - Tax $499.11 -3,650 8,465 -30% -$1.82M
D 2024-03-05 2024-03-01 ELV Todt Blair Williams EVP, CLO, CAO A - Grant $0.00 +8,312 8,312 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-01 A A 6,537 $0.00 17,156 D — — (F3) Represents performance based restricted share units. Restrictions lapse on 3/1/2024.
2 Common Common Stock 2024-03-01 A A 2,154 $0.00 10,619 D — — (F2) Represents restricted share units. Restrictions lapse as follows: 718 shares on 3/1/2025, 3/1/2026, and 3/1/2027.
3 Common Common Stock 2024-03-01 F D 3,650 $499.11 8,465 D — — (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
4 Derivative Employee Stock Option (Right to Buy) 2024-03-01 A A 8,312 $0.00 8,312 D $499.11 · — to 2034-03-01 8,312 Common Stock (F4) The option represents a right to purchase a total of 8,312 shares, and is exercisable in one installment of 2,770 shares, and two installments of 2,771 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date.